Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 442 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Figure S1 from Standard-Dose Pembrolizumab Plus Alternate-Dose Ipilimumab in Advanced Melanoma: KEYNOTE-029 Cohort 1C, a Phase 2 Randomized Study of Two Dosing Schedules
Georgina V. Long,Caroline Robert, Marcus O. Butler, Felix Couture, Matteo S. Carlino,Steven O'Day, Victoria Atkinson,Jonathan S. Cebon, Michael P. Brown, Stéphane Dalle, Andrew G. Hill,Geoffrey T. Gibney,Steven McCune, Alexander M. Menzies,Cuizhen Niu, Nageatte Ibrahim,Blanca Homet Moreno,Adi Diab
crossref（2024）
Cited0Views0Bibtex
0
0
282P Nivolumab and Ipilimumab Combination Treatment in Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer
O. Klein,M. Carlino, M. Brown, S. J. Harris,A. Gunjur,C. R. Underhill, R. Zielinski,D. Kee,W-S. Lam, H. Chan, R. A. Harrup, J. So, I. Collins, M. Michael,J. Torres, J. B. Palmer, D. Thomas, K. Wilkie,J. Cebon,A. Nagrial
Annals of Oncology (2024): S119-S119
Cited0Views0Bibtex
0
0
Combination immunotherapy in patients with rare cancers
A. Behren,A. Gunjur,D. Kee,B. Markman, M. Michael,C. Underhill,M. Carlino, L. Jackett, J. Duarte, L. Quigley,S. Ostrouska, J. Palmer, D. Adams,T. Lawley,J. Cebon,O. Klein
EUROPEAN JOURNAL OF IMMUNOLOGY (2023): 153-153
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 445

#Citation: 29767

H-Index: 79

G-Index: 167

Sociability: 8

Diversity: 4

Activity: 106

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn